Workflow
SCIENTURE Secures PBM-Led GPO Rebate Agreement to Drive Expanded Commercial Coverage and Formulary Access for Arbli™(losartan potassium) in the $256M U.S. Losartan Market
Globenewswire· 2025-09-16 20:05
Arbli™ is the first and only ready-to-use liquid formulation of losartan, eliminating the need for compounding while offering reduced dosing volume and extended room-temperature shelf life COMMACK, NY, Sept. 16, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through the development, commercialization, and distribution of novel specialty pr ...
Allied Provides Update on Non-Core Property Sales
Globenewswire· 2025-09-16 20:02
TORONTO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Allied Properties Real Estate Investment Trust ("Allied") (TSX: "AP.UN") today provided an update with respect to non-core property sales. “We initiated the sale process last year to fund the acquisition of larger than expected interests in 400 West Georgia, 19 Duncan and Calgary House,” said Michael Emory, Founder & Executive Chair. “We’ve continued this year with the immediate objective of improving access to the debt capital markets and the longer-term objectiv ...
New DualPack 3 IGBT7 Modules Deliver High Power Density and Simplify System Integration
Globenewswire· 2025-09-16 20:00
Microchip launches six variants targeting high-growth motor drive, data center and sustainability applicationsCHANDLER, Ariz., Sept. 16, 2025 (GLOBE NEWSWIRE) -- The growing need for compact, efficient and reliable power solutions is driving demand for power management devices that provide higher power density and simplify system design. Microchip Technology (Nasdaq: MCHP) today announces a new family of DualPack 3 (DP3) power modules featuring advanced IGBT7 technology available in six variants at 1200V an ...
EagleNXT Issues Shareholder Update on Corporate Rebrand and Strategic Outlook
Globenewswire· 2025-09-16 20:00
Rebrand aligns corporate identity with expanding opportunities in autonomy, defense and intelligence, reinforcing commitment to long-term shareholder value creation WICHITA, Kan., Sept. 16, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (dba, EagleNXT) (NYSE: UAVS), a leading provider of advanced drone and aerial imaging solutions, provides a shareholder update following its recently announced corporate name change, offering additional detail on the Company’s long-term strategy, market positioning, an ...
Rezolve Ai Strengthens Leadership with Appointment of Former Microsoft Retail Head Crispin Lowery as EVP, Growth
Globenewswire· 2025-09-16 20:00
Seasoned tech executive to accelerate adoption of Rezolve’s proprietary AI commerce platform, building on Microsoft, Google, and Tether partnerships.NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), a leader in proprietary AI-powered commerce solutions, today announced the appointment of Crispin Lowery as Executive Vice President, Growth. Lowery, who most recently led Microsoft’s Retail & Consumer Goods (EMEA) and spent eight years at Google, will spearhead Rezolve’s global expansion a ...
HCW Biologics Designates One of Its Proprietary TRBC-Pembrolizumab-Based Immune Checkpoint Inhibitors as its Franchise Immunotherapeutic for Internal Clinical Development
Globenewswire· 2025-09-16 20:00
核心观点 - 公司宣布其基于TRBC平台的领先候选产品HCW11-040在临床前研究中表现出优于pembrolizumab单药的免疫激活和抗肿瘤效果 并将推进至IND申报研究阶段 用于实体瘤治疗 [1][2][3][4] 产品研发进展 - 领先候选产品HCW11-040为多功能融合蛋白 包含pembrolizumab(Keytruda)、IL-7、IL-15及TGF-β受体组件(TGF-β traps)[2] - 临床前研究表明该分子能扩增TPEX细胞并促进其分化为抗癌效应T细胞 且不会引发细胞因子风暴 [2][3] - 在免疫细胞活化与扩增、肿瘤浸润增强及癌细胞杀伤力方面均优于pembrolizumab单药治疗 [3] - 公司计划开展后期IND申报研究 包括建立高表达生产细胞库、化学制造控制工艺开发及GLP毒理学研究 [4] 技术平台与管线 - TRBC技术平台可构建三类免疫治疗化合物:多功能免疫细胞刺激剂、第二代免疫检查点抑制剂、多特异性靶向融合蛋白及增强型免疫细胞衔接器 [6] - 平台已构建超过50个分子 包括HCW11-002、HCW11-006、HCW11-018及HCW11-040 目前正进行进一步临床前评估 [6] - 公司另拥有传统TOBI™平台 用于开发先导产品HCW9302 [6] 公司战略与业务模式 - 专注于通过新型免疫疗法治疗慢性炎症相关疾病 尤其年龄相关及衰老相关疾病 [5] - 拥有两项授权计划 已对部分专有分子授予独家权利 [6] - 通过科学研讨会(如2025年9月12日在诺瓦东南大学举办的会议)分享关键数据以强化学术合作与影响力 [1][4]
Izotropic Publishes New FAQ Page for Investors, Analysts, and Healthcare Decision-Makers
Globenewswire· 2025-09-16 20:00
VANCOUVER, British Columbia, and SACRAMENTO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- via IBN –Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces the launch of a new Frequently Asked Questions (“FAQ”) page on its corporate website. The new FAQ resource, available at www.izocorp.c ...
Turbo Energy Secures $53 Million Contract to Deploy 366 Mwh of Solar Storage Capacity Across 10 Factories
Globenewswire· 2025-09-16 20:00
VALENCIA, Spain, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Turbo Energy S.A. (Nasdaq: TURB) (“Turbo Energy” or the “Company”), a global provider of leading-edge, AI-optimized solar energy storage technologies and solutions, today announced that it has been selected to supply and implement energy storage projects in Spain with a total capacity of 366 MWh. The projects, valued at approximately $53 million, are scheduled to be executed over the next two years. This large-scale initiative will be developed for a major ...
Avadel Pharmaceuticals Celebrates Five Years of Driving Growth in Sleep Research Funding
Globenewswire· 2025-09-16 20:00
A Media Snippet accompanying this announcement is available by clicking on this link. DUBLIN, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The American Academy of Sleep Medicine Foundation (AASM Foundation) and Avadel Pharmaceuticals are celebrating five years of collaboration and dedicated support for early-career sleep researchers and future sleep physicians. In 2021, Avadel became the Young Investigator Research Forum’s (YIRF) inaugural corporate sponsor. Thanks to support from Avadel and other companies, YIRF ha ...
YSX TECH. CO., LTD Enters into a Memorandum of Understanding with XUnit to Jointly Build a Compliance-Driven Real-world Asset Standardization Platform
Globenewswire· 2025-09-16 20:00
GUANGZHOU, China, Sept. 16, 2025 (GLOBE NEWSWIRE) -- YSX TECH. CO., LTD (NASDAQ: “YSXT”) (the “Company”), a Cayman Islands exempted company that, through its variable interest entities in China, provides comprehensive business solutions mainly for insurance companies and brokerages in China, today announced that the Company and XUnit, a company that operates a real-world assets (“RWA”) and non-fungible token infrastructure platform deployed on X Layer, have entered into a memorandum of understanding (the “M ...